Pacala Mark L 4
4 · Oncology Institute, Inc. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Pacala Mark L
Director
Transactions
- Sale
Common Stock
2025-11-18$4.00/sh−2,160$8,640→ 222,811 total - Sale
Common Stock
2025-11-18$4.00/sh−46,630$186,520→ 174,971 total - Sale
Common Stock
2025-11-18$4.00/sh−1,210$4,840→ 221,601 total
Footnotes (1)
- [F1]Represents sale of Common Stock acquired from previously vested RSU awards.